| Literature DB >> 24421316 |
Shoichi Kubota1, Yasunori Fukumoto, Kenichi Ishibashi, Shuhei Soeda, Sho Kubota, Ryuzaburo Yuki, Yuji Nakayama, Kazumasa Aoyama, Noritaka Yamaguchi, Naoto Yamaguchi.
Abstract
Mimosine is an effective cell synchronization reagent used for arresting cells in late G1 phase. However, the mechanism underlying mimosine-induced G1 cell cycle arrest remains unclear. Using highly synchronous cell populations, we show here that mimosine blocks S phase entry through ATM activation. HeLa S3 cells are exposed to thymidine for 15 h, released for 9 h by washing out the thymidine, and subsequently treated with 1 mM mimosine for a further 15 h (thymidine → mimosine). In contrast to thymidine-induced S phase arrest, mimosine treatment synchronizes >90% of cells at the G1-S phase boundary by inhibiting the transition of the prereplication complex to the preinitiation complex. Mimosine treatment activates ataxia telangiectasia mutated (ATM)/ataxia telangiectasia and Rad3-related (ATR)-mediated checkpoint signaling without inducing DNA damage. Inhibition of ATM activity is found to induce mimosine-arrested cells to enter S phase. In addition, ATM activation by mimosine treatment is mediated by reactive oxygen species (ROS). These results suggest that, upon mimosine treatment, ATM blocks S phase entry in response to ROS, which prevents replication fork stalling-induced DNA damage.Entities:
Keywords: Cell Cycle; Checkpoint Control; DNA Damage Response; DNA Replication; Oxidative Stress
Mesh:
Substances:
Year: 2014 PMID: 24421316 PMCID: PMC3937646 DOI: 10.1074/jbc.M113.546655
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157